Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04240106
Title Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Acronym LUZERN
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Centro Oncologico de Galicia A Coruña 15009 Spain Details
Hospital Uniersitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clínic i provincial de Barcelona Barcelona 08036 Spain Details
Hospital Universitario Reina Sofía Córdoba 28091 Spain Details
Hospital Clinico San Carlos Madrid 28041 Spain Details
Hospital Universitario 12 de octubre Madrid 28041 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
Hospital Clínico Universitario de Santiago de Compostela Santiago De Compostela 15706 Spain Details
Instituto Valenciano de Oncología Valencia 46009 Spain Details
Complejo Asistencial de Ávila Ávila 05071 Spain Details
*Shaded cells indicate that there was no data available from for the field